Pathologic Bone Resorption and New Bone Formation in Inflammatory Arthritis

• 1. Peng Y
  2. Kenney HM
  3. Lydon S
  4. de Mesy Bentley KL
  5. Xing L
  6. Korman BD
  7. Ritchlin CT
  8. Schwarz EM
  The Function of Efhd1+ Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis.; bioRxiv : the preprint server for biology. 2025 Nov 05.
• 1. McInnes IB
  2. Coates LC
  3. Mease PJ
  4. Ogdie A
  5. Kavanaugh A
  6. Eder L
  7. Schett G
  8. Kivitz A
  9. McGonagle D
  10. Brennan N
  11. Godwood A
  12. Cullen E
  13. Reich K
  14. Ritchlin CT
  15. Merola JF
  Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.; Nature medicine. 2025 Oct 06.
• 1. Mease PJ
  2. Coates LC
  3. Gaillez C
  4. Shew A
  5. Bao W
  6. Ritchlin CT
  Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years.; Rheumatology (Oxford, England). 2025 Sep 18.
• 1. Mease PJ
  2. Ritchlin CT
  3. Coates LC
  4. Kollmeier AP
  5. Zhou B
  6. Jiang Y
  7. Bensley K
  8. Im K
  9. Batra R
  10. Chakravarty SD
  11. Rahman P
  12. van der Heijde D
  Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study.; Annals of the rheumatic diseases. 2025 Sep 16.

November 21, 2025
Rangel-Moreno an International Speaker at the Research Seminars in Biological Sciences and International Biomedicine Workshop

October 22, 2025
Jennifer Anolik Presents at Upstate Medical Center Symposium

October 20, 2025
National Scleroderma Foundation Rochester Education Forum Held at URMC

September 29, 2025
Jessica Stern, MD Awarded a Mentored Patient-Oriented Research Career Development Award (K23)

May 23, 2025
AIR Research Presented at the 2025 AAI Meeting

All News »